Virtual reality technology transforming COVID-19 drug discovery
Nanome’s virtual reality tech is being put to use by Oak Ridge National Laboratory and top pharma firms to study COVID-19 and explore drug candidates.
Nanome’s virtual reality tech is being put to use by Oak Ridge National Laboratory and top pharma firms to study COVID-19 and explore drug candidates.
A leader from Longboat by Advarra outlines what it really means for a study to be patient centric, and how to succeed in achieving patient-centric trials.
A representative from Tools4Patient discusses how grasping the ties between the two can help in reducing the impact of the placebo response in trials.